KINTARA THERAPEUTICS INC (KTRA)

US49720K2006 - Common Stock

0.1626  +0.01 (+9.27%)

After market: 0.1597 0 (-1.78%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-12-31)
2023
(2023-6-30)
2022
(2022-6-30)
2021
(2021-6-30)
2020
(2020-6-30)
Revenue
0.000.000.000.000.00
Operating Expenses
10.63M14.80M22.68M37.67M8.15M
Research and Development
6.06M9.31M15.17M27.91M3.63M
Selling, General, and Administrative Expenses
4.58M5.49M7.51M9.76M4.51M
Operating Income
-10.63M-14.80M-22.68M-37.67M-8.15M
Interest Income/Expense
46.00K150.00K20.00K-130.00K70.00K
Other Income/Expense
N/AN/AN/AN/AN/A
Non Recurring Items
N/AN/A0.00-500.00K-1.05M
Income Before Taxes
-10.58M-14.65M-22.66M-38.30M-9.13M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-10.78M-15.02M-25.13M-41.50M-9.13M
EBITDA
-10.57M-14.74M-22.62M-37.64M-8.14M
 
Per Share Data
EPS Diluted Total Ops
-5.98-9.27-25.90-79.80-43.47
Non GAAP EPS
N/A-9.49-25.50-39.00N/A
 
Statistics

All data in USD

Charts